Linda Grais

CIK 1413306 · President and CEO · last filed 2025-06-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$119.3K

Companies

4

Total Filings

53

Lifetime Open-Market Net

-$1.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRVS Director 10,000 $11.93 $119.3K $24.5K 13 2025-06-16
Oruka Therapeutics, Inc. (ABIO) Delisted Director 491,889 $28.80 $14.17M -$1.55M 14 2024-01-31
PRA Health Sciences, Inc. (PRAH) Delisted Director 0 $165.21 $0 $0 8 2021-07-01
Zosano Pharma Corp (ZSAN) Delisted Director 22,500 $0.56 $12.5K $0 5 2021-06-14

Recent Filings · Page 4 of 6

53 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-02-21 Oruka Therapeutics, Inc. (ABIO) Delisted Grant (A) $0 EDGAR
2016-12-16 Grant (A) $0
2016-12-08 Buy (P) +7,000 $15.0K
2016-06-20 PRA Health Sciences, Inc. (PRAH) Delisted Grant (A) +1,466 $0 EDGAR
2016-03-07 Buy (P) +3,000 $9.6K
2016-02-16 Oruka Therapeutics, Inc. (ABIO) Delisted Grant (A) $0 EDGAR
2016-01-25 Buy (P) +10,000 $23.8K
2016-01-19 Buy (P) +10,000 $20.8K
2016-01-07 Grant (A) $0
2015-10-13 PRA Health Sciences, Inc. (PRAH) Delisted Grant (A) +2,582 $0 EDGAR
Showing 3140 of 53
Page 4 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.